Literature DB >> 8511596

The epidemiology of ankylosing spondylitis.

J T Gran1, G Husby.   

Abstract

This review focuses on various epidemiological aspects of ankylosing spondylitis (AS). Diagnostic criteria currently available are described, and their use in scientific studies as opposed to everyday clinical practice is discussed. Present knowledge of the prevalence of AS is addressed in detail with particular emphasis on discrepancies caused by variations in population frequencies of HLA B27 and those caused by differences in study designs.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8511596     DOI： 10.1016/s0049-0172(05)80011-3

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN： 0049-0172            Impact factor:   5.532


  36 in total

Review 1.  [Quality indicators for managing patients with low back pain].

Authors:  J F Chenot
Journal:  Schmerz       Date:  2010-06       Impact factor: 1.107

Review 2.  International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis.

Authors:  J Braun; T Pham; J Sieper; J Davis; Sj van der Linden; M Dougados; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103

Review 3.  Epidemiology of HLA-B27 and Arthritis.

Authors:  M A Khan
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

4.  Profile of ankylosing spondylitis in Saudi Arabia.

Authors:  A al-Arfaj
Journal:  Clin Rheumatol       Date:  1996-05       Impact factor: 2.980

Review 5.  Review for Disease of the Year: Epidemiology of HLA-B27 Associated Ocular Disorders.

Authors:  Laura J Kopplin; George Mount; Eric B Suhler
Journal:  Ocul Immunol Inflamm       Date:  2016-05-27       Impact factor: 3.070

Review 6.  The health-related quality of life of ankylosing spondylitis patients assessed by SF-36: a systematic review and meta-analysis.

Authors:  Xiao Yang; Dazhi Fan; Qing Xia; Mengmeng Wang; Xu Zhang; Xiaona Li; Guoqi Cai; Li Wang; Lihong Xin; Shengqian Xu; Faming Pan
Journal:  Qual Life Res       Date:  2016-06-20       Impact factor: 4.147

7.  Increased risk of stroke among patients with ankylosing spondylitis: a population-based matched-cohort study.

Authors:  Joseph J Keller; Jung-Lung Hsu; Shiue-Ming Lin; Chia-Chi Chou; Li-Hsuan Wang; Jui Wang; Chyi-Huey Bai; Hung-Yi Chiou
Journal:  Rheumatol Int       Date:  2013-12-10       Impact factor: 2.631

8.  Socioeconomic impact of ankylosing spondylitis in Morocco.

Authors:  Hanan Rkain; Fadoua Allali; Aziza Bentalha; Noufissa Lazrak; Redouane Abouqal; Najia Hajjaj-Hassouni
Journal:  Clin Rheumatol       Date:  2007-04-25       Impact factor: 2.980

Review 9.  Ankylosing spondylitis. Not just another pain in the back.

Authors:  Walter P Maksymowych
Journal:  Can Fam Physician       Date:  2004-02       Impact factor: 3.275

10.  Physical function, disease activity, and health-related quality-of-life outcomes after 3 years of adalimumab treatment in patients with ankylosing spondylitis.

Authors:  Désirée M van der Heijde; Dennis A Revicki; Katherine L Gooch; Robert L Wong; Hartmut Kupper; Neesha Harnam; Chris Thompson; Joachim Sieper
Journal:  Arthritis Res Ther       Date:  2009-08-17       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.